Literature DB >> 8416410

Cats and toxoplasmosis risk in HIV-infected adults.

M R Wallace1, R J Rossetti, P E Olson.   

Abstract

OBJECTIVE: To establish the prevalence and incidence of toxoplasmosis in an adult human immunodeficiency virus (HIV) population, and to determine if cat ownership contributes to the risk of toxoplasmosis.
DESIGN: Retrospective record and laboratory review, coupled with a patient survey.
SETTING: A tertiary-care military hospital HIV program. PATIENTS: A total of 723 HIV-infected adults, all former or current US military personnel. MAIN OUTCOME MEASURES: Prevalence and incidence of serologic evidence of toxoplasmosis infection.
RESULTS: A total of 723 HIV-infected patients had serial Toxoplasma IgG antibody determinations. Seventy patients (9.7%) were positive on their initial screen; the seronegative patients were tested annually for 1 to 5 years (mean duration of follow-up, 2.1 years). Only 13 patients (2.0%) who were initially seronegative acquired antibodies to Toxoplasma gondii. None of the patients who seroconverted developed clinical disease. A pet history was available on 12 of 13 patients who seroconverted; only one (8.3%) had owned or lived in a household with a cat during the period of seroconversion. The calculated attributable risk of cat ownership/exposure for toxoplasmosis seroconversion in this population is -2.9 per 100 persons annually.
CONCLUSION: Toxoplasma antibody seroconversion in an adult HIV-infected population is unusual and appears unrelated to cat ownership or exposure.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8416410

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  11 in total

1.  Toxoplasma gondii calcium-dependent protein kinase 1 is a target for selective kinase inhibitors.

Authors:  Kayode K Ojo; Eric T Larson; Katelyn R Keyloun; Lisa J Castaneda; Amy E Derocher; Krishna K Inampudi; Jessica E Kim; Tracy L Arakaki; Ryan C Murphy; Li Zhang; Alberto J Napuli; Dustin J Maly; Christophe L M J Verlinde; Frederick S Buckner; Marilyn Parsons; Wim G J Hol; Ethan A Merritt; Wesley C Van Voorhis
Journal:  Nat Struct Mol Biol       Date:  2010-05-02       Impact factor: 15.369

2.  Caring for pets of immunocompromised persons.

Authors:  F J Angulo; C A Glaser; D D Juranek; M R Lappin; R L Regnery
Journal:  Can Vet J       Date:  1995-04       Impact factor: 1.008

3.  Risk factors for recent toxoplasma infection in pregnant women in Naples.

Authors:  W Buffolano; R E Gilbert; F J Holland; D Fratta; F Palumbo; A E Ades
Journal:  Epidemiol Infect       Date:  1996-06       Impact factor: 2.451

4.  Risk factors for Toxoplasma infection in a reproductive age female population in the area of Belgrade, Yugoslavia.

Authors:  B Bobić; I Jevremović; J Marinković; D Sibalić; O Djurković-Djaković
Journal:  Eur J Epidemiol       Date:  1998-09       Impact factor: 8.082

5.  Pet ownership among persons with AIDS in three Florida counties.

Authors:  L Conti; S Lieb; T Liberti; M Wiley-Bayless; K Hepburn; T Diaz
Journal:  Am J Public Health       Date:  1995-11       Impact factor: 9.308

6.  Central Nervous System Toxoplasmosis in HIV Pathogenesis, Diagnosis, and Therapy.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-08       Impact factor: 3.663

7.  Preventing zoonotic diseases in immunocompromised persons: the role of physicians and veterinarians.

Authors:  S Grant; C W Olsen
Journal:  Emerg Infect Dis       Date:  1999 Jan-Feb       Impact factor: 6.883

8.  Highly endemic, waterborne toxoplasmosis in north Rio de Janeiro state, Brazil.

Authors:  Lílian Maria Garcia Bahia-Oliveira; Jeffrey L Jones; Juliana Azevedo-Silva; Cristiane C F Alves; Fernando Oréfice; David G Addiss
Journal:  Emerg Infect Dis       Date:  2003-01       Impact factor: 6.883

9.  Seroprevalence and risk factors for Toxoplasmosis in HIV infected and non-infected individuals in Bahir Dar, Northwest Ethiopia.

Authors:  Fisseha Walle; Nigatu Kebede; Aster Tsegaye; Tesfu Kassa
Journal:  Parasit Vectors       Date:  2013-01-16       Impact factor: 3.876

10.  Therapy and prophylaxis of opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066).

Authors:  J Thoden; A Potthoff; J R Bogner; N H Brockmeyer; S Esser; K Grabmeier-Pfistershammer; B Haas; K Hahn; G Härter; M Hartmann; C Herzmann; J Hutterer; A R Jordan; C Lange; S Mauss; D Meyer-Olson; F Mosthaf; M Oette; S Reuter; A Rieger; T Rosenkranz; M Ruhnke; B Schaaf; S Schwarze; H J Stellbrink; H Stocker; A Stoehr; M Stoll; C Träder; M Vogel; D Wagner; C Wyen; C Hoffmann
Journal:  Infection       Date:  2013-09-14       Impact factor: 3.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.